Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-02-07
2010-02-23
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S053000, C514S054000, C604S060000, C604S068000, C604S187000, C604S890100, C536S001110, C536S123100, C536S123130, C424S423000
Reexamination Certificate
active
07666844
ABSTRACT:
Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.
REFERENCES:
patent: 3948263 (1976-04-01), Drake et al.
patent: 4015033 (1977-03-01), Nield
patent: 4089334 (1978-05-01), Schwebel et al.
patent: 4153406 (1979-05-01), Dittmann et al.
patent: 4671953 (1987-06-01), Stanley et al.
patent: 4697575 (1987-10-01), Horowitz
patent: 4920727 (1990-05-01), Ristamaki et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 5153002 (1992-10-01), McMullen et al.
patent: 5356635 (1994-10-01), Raman et al.
patent: 5372590 (1994-12-01), Haber et al.
patent: 5403595 (1995-04-01), Kitchell et al.
patent: 5429822 (1995-07-01), Gresser et al.
patent: 5434146 (1995-07-01), Labrie et al.
patent: 5486362 (1996-01-01), Kitchell et al.
patent: 5525352 (1996-06-01), Kontos et al.
patent: 5536503 (1996-07-01), Kitchell et al.
patent: 5541172 (1996-07-01), Labrie et al.
patent: 5542920 (1996-08-01), Cherif-Cheikh
patent: 5543156 (1996-08-01), Roorda et al.
patent: 5567439 (1996-10-01), Myers et al.
patent: 5582591 (1996-12-01), Cheikh
patent: 5595760 (1997-01-01), Cherif-Cheikh
patent: 5616123 (1997-04-01), Cheikh
patent: 5629303 (1997-05-01), Labrie et al.
patent: 5633000 (1997-05-01), Grossman et al.
patent: 5656298 (1997-08-01), Kitchell et al.
patent: 5660846 (1997-08-01), Cheikh
patent: 5695463 (1997-12-01), Cherif-Cheikh
patent: 5716981 (1998-02-01), Hunter et al.
patent: 5762961 (1998-06-01), Roser et al.
patent: 5766637 (1998-06-01), Shine et al.
patent: 5776107 (1998-07-01), Cherif-Cheikh
patent: 5783567 (1998-07-01), Hedley et al.
patent: 5814340 (1998-09-01), Labrie et al.
patent: 5817343 (1998-10-01), Burke
patent: 5823994 (1998-10-01), Sharkey et al.
patent: 5833891 (1998-11-01), Subramaniam et al.
patent: 5837276 (1998-11-01), Cheikh
patent: 5851547 (1998-12-01), Fujioka et al.
patent: 5858388 (1999-01-01), Grossman et al.
patent: 5861387 (1999-01-01), Labrie et al.
patent: 5874029 (1999-02-01), Subramaniam et al.
patent: 5886026 (1999-03-01), Hunter et al.
patent: 5929196 (1999-07-01), Kissel et al.
patent: 5945128 (1999-08-01), Deghenghi
patent: 5980948 (1999-11-01), Goedemoed et al.
patent: 5994341 (1999-11-01), Hunter et al.
patent: 6004573 (1999-12-01), Rathi et al.
patent: 6077523 (2000-06-01), Deghenghi
patent: 6098675 (2000-08-01), Runft
patent: 6117949 (2000-09-01), Rathi et al.
patent: 6126956 (2000-10-01), Grossman et al.
patent: 6139574 (2000-10-01), Vacanti et al.
patent: 6143037 (2000-11-01), Goldstein et al.
patent: 6149864 (2000-11-01), Dillow et al.
patent: 6159490 (2000-12-01), Deghenghi
patent: 6176874 (2001-01-01), Vacanti et al.
patent: 6183781 (2001-02-01), Burke
patent: 6193994 (2001-02-01), Lee et al.
patent: 6197575 (2001-03-01), Griffith et al.
patent: 6201072 (2001-03-01), Rathi et al.
patent: 6224630 (2001-05-01), Bao et al.
patent: 6224794 (2001-05-01), Amsden et al.
patent: 6231904 (2001-05-01), Mueller
patent: 6232340 (2001-05-01), Zhang et al.
patent: 6241771 (2001-06-01), Gresser et al.
patent: 6290991 (2001-09-01), Roser et al.
patent: 6485453 (2002-11-01), Buch-Rasmussen et al.
patent: 2002/0111603 (2002-08-01), Cherif-Cheikh
patent: 2003/0054044 (2003-03-01), Potter et al.
patent: 2003/0161881 (2003-08-01), Hansen et al.
patent: 2003/0234466 (2003-12-01), Buch-Rasmussen et al.
patent: 1 196 864 (1985-11-01), None
patent: 0 049 068 (1985-12-01), None
patent: 0 838 209 (2000-04-01), None
patent: 1 092 433 (2001-04-01), None
patent: 2 091 554 (1982-04-01), None
patent: WO 92/02211 (1992-02-01), None
patent: WO 93/10758 (1993-06-01), None
patent: WO 93/17662 (1993-09-01), None
patent: WO 93/23110 (1993-11-01), None
patent: WO 94/22423 (1994-10-01), None
patent: WO 94/22423 (1994-10-01), None
patent: WO 94/24263 (1994-10-01), None
patent: WO 96/03978 (1996-02-01), None
patent: WO 96/07397 (1996-03-01), None
patent: WO 96/07398 (1996-03-01), None
patent: WO 96/07440 (1996-03-01), None
patent: WO 96/07440 (1996-03-01), None
patent: WO 96/08289 (1996-03-01), None
patent: WO 96/03978 (1996-10-01), None
patent: WO 99/33853 (1999-07-01), None
patent: WO 00/32071 (2000-06-01), None
patent: WO 00/53160 (2000-09-01), None
patent: WO 00/62759 (2000-10-01), None
patent: WO 01/35932 (2001-05-01), None
patent: WO 01/35932 (2001-05-01), None
patent: WO 01/37804 (2001-05-01), None
patent: WO 01/37804 (2001-05-01), None
Response submitted Sep. 9, 2008 in U.S. Appl. No. 10/322,143 by Hansen et al.
Office Action dated Sep. 29, 2008 in U.S. Appl. No. 10/322,143 by Hansen et al., filed Dec. 18, 2002.
Office Action dated Sep. 5, 2008 in U.S. Appl. No. 10/341,142 by Buch-Rasmussen et al., filed Jan. 13, 2003.
Response submitted Feb. 5, 2009 in U.S. Appl. No. 10/341,142 by Buch-Rasmussen et al.
Yamakawa, “Sustained Release of Insulin by Double Layered Implant using poly(D,L-lactic acid),” J. Pharm Sciences, vol. 79, No. 6, pp. 505-509, Jun. 1990.
Office Action dated May 8, 2008 in U.S. Appl. No. 10/322,143 by Hansen et al., filed Dec. 18, 2002.
Office Action dated Feb. 25, 2008 in U.S. Appl. No. 10/341,142 by Buch-Rasmussen et al., filed Jan. 13, 2003.
Aasmul Søren
Buch-Rasmussen Thomas
Flink James M.
Hansen Philip
Mortensen Claus Juul
Began Marc A.
Green Reza
Nicolas Wesley A.
Novo Nordisk A S
Ward Paul V.
LandOfFree
Dry mouldable drug formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dry mouldable drug formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dry mouldable drug formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4151160